← Open Payments lookup

HANNAH KESLER: Open Payments

NPI 1255805099 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,246 in 106 payments from 13 companies in 2025. Trend: 2023 $2,301 · 2024 $1,147 · 2025 $2,246

Food & beverage: $2,246
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$593
Otsuka America Pharmaceutical, Inc.12$396
Vanda Pharmaceuticals Inc.14$370
ABBVIE INC.23$223
E.R. Squibb & Sons, L.L.C.5$113
Axsome Therapeutics, Inc.4$107
Lundbeck LLC4$98
Takeda Pharmaceuticals U.S.A., Inc.4$77
Janssen Pharmaceuticals, Inc4$75
Alkermes, Inc.3$70

Products named: CAPLYTA, REXULTI, FANAPT, VRAYLAR, COBENFY, Auvelity, TRINTELLIX, SPRAVATO.

Industry payments across AL — which companies pay providers there.